Market Overview

18 Biggest Mid-Day Gainers For Friday

Share:

 

  • Acacia Communications, Inc. (NASDAQ: ACIA) surged 32.5 percent to $89.72 following Q2 results. Acacia Communications reported quarterly non-GAAP earnings of $0.77 per share on revenue of $116.2 million. The company expects Q3 non-GAAP earnings of $0.64 to $0.76 per share, on revenue of $120 million to $128 million.
  • NovaBay Pharmaceuticals, Inc. (NYSE: NBY) shares climbed 30.4 percent to $3.20 following Q2 results. NovaBay Pharma reported a Q2 loss of $0.36 per share on revenue of $2.7 million.
  • Silicon Graphics International Corp (NASDAQ: SGI) shares climbed 28.8 percent to $7.70 after Hewlett Packard Enterprise Co (NYSE: HPE) announced plans to acquire the company for around $275 million.
  • Sunrun Inc (NASDAQ: RUN) shares climbed 17.4 percent to $6.35 as the company posted strong Q2 results.
  • Cosi Inc (NASDAQ: COSI) gained 16.7 percent to $0.262 following Q2 results. Cosi reported a Q2 loss of $0.07 per share on revenue of $22.8 million.
  • AveXis Inc (NASDAQ: AVXS) shares surged 14.6 percent to $39.87. AveXis posted a narrower-than-expected Q2 loss. Jefferies upgraded AveXis from Hold to Buy.
  • Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares jumped 13.1 percent to $4.56. Eleven Biotherapeutics reported a Q2 loss of $0.33 per share on revenue of $0.3 million and issued a strategic update.
  • Cinedigm Corp (NASDAQ: CIDM) rose 12.2 percent to $2.12. Cinedigm is expected to report Q1 financial results on Monday, August 15, 2016.
  • InvenSense Inc (NYSE: INVN) gained 12.1 percent to $7.62. Pacific Crest upgraded InvenSense from Sector Weight to Overweight.
  • Planet Fitness Inc (NYSE: PLNT) shares climbed 10.1 percent to $22.39 as the company posted upbeat earnings for its second quarter on Thursday. The company raised FY 2016 revenue guidance to $366 million to $372 million, from $360 million to $370 million.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) shares surged 10 percent to $6.93 after gaining 7.88 percent on Thursday.
  • Itron, Inc. (NYSE: ITRI) shares gained 9.1 percent to $47.65. Itron posted upbeat quarterly results.
  • Delek US Holdings, Inc. (NYSE: DK) shares gained 8.9 percent to $16.22. CVR Energy, Inc. is said to be planning to make an offer to acquire Delek US, according to sources as reported by the NY Post on Thursday. Carl Icahn owns a controlling stake in CVR and it thought to be building a stake in Delek, the sources said.
  • Nordstrom, Inc. (NYSE: JWN) shares surged 8.8 percent to $51.73 as the company reported better-than-expected earnings for its second quarter.
  • Mistras Group Inc (NYSE: MG) rose 7.6 percent to $24.55. Baird upgraded MISTRAS Group from Neutral to Outperform.
  • CVR Energy, Inc. (NYSE: CVI) gained 4.5 percent to $14.33. CVR Energy is said to be planning to make an offer to acquire Delek US, according to sources as reported by the NY Post on Thursday.
  • NVIDIA Corporation (NASDAQ: NVDA) shares rose 3.8 percent to $61.99 as the company reported stronger-than-expected Q2 results after market close on Thursday. NVIDIA saw Q3 revenues at $1.68 billion plus or minus 2 percent vs. estimates of $1.45. Additionally, management forecasted Q3 non-GAAP gross margins to be 58.0 percent.
  • J C Penney Company Inc (NYSE: JCP) rose 3.7 percent to $10.31 as the company reported a narrower-than-expected loss for the second quarter and reaffirmed its outlook for the full year 2016.

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers

 

Related Articles (AVXS + ACIA)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Barclays Says Investors Underestimate St. Jude Medical 's Potential

Credit Suisse Has Near-Term Concerns For Gold, Remains Positive Long-Term